FeRiva Generic Name: highly soluble oral tablets Brand Name: FeRiva side effects drug center feriva (highly soluble oral tablets) drug Related Drugs BiferaRx Folic Acid Monoferric Triferic AVNU PROFESSIONAL SIDE EFFECTS Contents Drug Description Indications & Dosage Side Effects & Drug Interactions Warnings & Precautions Overdosage & Contraindications Clinical Pharmacology Medication Guide Drug Description FeRiva 21/7 (ascorbic acid, zinc glycinate, cyanocobalamin, ferrous asparto glycinate, folic acid, docusate sodium and succinic acid) Tablets WARNING Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. DESCRIPTION FeRiva 21/7™ tablets for oral administration is a 28-day iron supplement regimen that consists of 21 red, oval-shaped iron tablets and 7 purple, oval-shaped placebo tablets. Each red, oval-shaped iron tablet is debossed with “21” and “7” separated by line in the middle on the top-side of the tablet and blank on the other side. Each purple, oval shaped placebo tablet is blank on both sides of the tablet. Indications & Dosage INDICATIONS FeRiva 21/7™ tablets for oral administration is a 28-day iron supplement regimen. DOSAGE AND ADMINISTRATION Usual dosage is one tablet daily with or without food or as prescribed by your healthcare provider. The FeRiva 21/7™ Tablets blister pack supplies a 28-day course of iron therapy that consists of 21 red iron tablets and 7 purple placebo tablets. Take 1 red iron tablet daily for 21 days, followed by 1 purple placebo tablet daily for 7 days. After 28 tablets have been taken a new course may be started if prescribed. Supplement Facts Serving Size: 1 tablet % Daily Value % Daily Value for Pregnant & Lactating Women Each Red Iron Tablet Contains : Vitamin C (as Ascorbic Acid) 175 mg 292% 292% Zinc (as Zinc Bisglycinate) 10 mg 67% 67% Vitamin B12 (as Cyanocobalamin) 12 mcg 200% 150% Iron (as Ferrrous Asparto Glycinate) Sumalate® 75 mg 417% 417% Folate (as ((6S)-N5- methyltetrahydrofolic acid calcium salt (molar equivalent to 600 mcg of folic acid) and folic acid, USP 400 mcg) 1 mg 250% 125% Docusate Sodium 50 mg * * Succinic Acid 150 mg * * PURPLE PLACEBO TABLETS do not contain ANY vitamins, minerals or other dietary ingredients. Please see Other Ingredients section below for the listing of the placebo ingredients. * Daily Value (DV) not established. Other Ingredients (Red Iron Tablets) Dicalcium phosphate, microcrystalline cellulose, stearic acid, silicon dioxide, magnesium stearate and croscarmellose sodium. HOW SUPPLIED FeRiva 21/7™tablets blister pack (75854-318-28) contains 21 red iron tablets and 7 purple placebo tablets. The listed product number is not a National Drug Code. Instead Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and health insurance computer systems. Storage Store between 20°- 25°C (68°- 77°F) Distributed By: Avion Pharmaceuticals, LLC. Revised: Oct 2014 Side Effects & Drug Interactions SIDE EFFECTS Health Claims Allergic sensitization has been reported following both oral and parenteral administration of folic acid. DRUG INTERACTIONS No Information Provided Warnings & Precautions WARNINGS Included as part of the PRECAUTIONS section. PRECAUTIONS Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. While prescribing this nutritional supplement for pregnant women, nursing mothers or for women prior to conception, their medical condition and other drugs, herbs and/or supplements consumption should be considered. Overdosage & Contraindications OVERDOSE No Information Provided CONTRAINDICATIONS No Information Provided Clinical Pharmacology CLINICAL PHARMACOLOGY No Information Provided Medication Guide PATIENT INFORMATION No information provided. Please refer to the WARNINGS AND PRECAUTIONS sections.
